Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma

Abstract

Recently, we cloned a novel sulfatase domain-containing downregulated gene, HSulf-1, which modulates heparin-binding growth factor signaling in ovarian cancer. Based on the pilot data showing the loss of HSulf-1 in head and neck squamous cell carcinoma cell lines (SCCHN), we sought to employ SCCHN as a model to define the role of HSulf-1 in the molecular regulation of tumorigenecity. Three SCCHN lines (012SCC, WMMSCC, and 015SCC) had no detectable HSulf-1 mRNA. Clonal lines of HSulf-1-expressing 012SCC attenuated the activation of ERK/mitogen-activated protein kinase (MAPK) signaling mediated by fibroblast growth factor (FGF-2) and both ERK/MAPK and Akt signaling mediated by hepatocyte growth factor (HGF). Consistent with this downregulation, phosphorylation of HGF receptor, c-Met, which is frequently overexpressed in SCCHN, was also attenuated in HSulf-1 clonal 012SCC cell lines. HGF markedly enhanced the motility and migration of vector-transfected cells in a transwell invasion chamber. However, HGF-mediated motility and invasion was attenuated in HSulf-1 clonal 012SCC cell lines. In addition, transfected cells displayed significant growth inhibition concomitant with a decrease in mitogenecity, as measured by thymidine incorporation and increased sensitivity to staurosporine- and cisplatin-induced apoptosis. These data suggest that HSulf-1 normally functions as a negative regulator in cell growth and loss of HSulf-1 in SCCHN potentiates growth factor signaling, enhances motility, invasiveness and inhibits stress-induced apoptosis, with a resulting increase in tumorigenecity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Betz CS, Lai JP, Xiang W, Janda P, Heinrich P, Stepp H, Baumgartner R and Leunig A . (2002). Photochem. Photobiol. Sci., 1, 315–319.

    Article  CAS  Google Scholar 

  • Bhalla US, Ram PT and Iyengar R . (2002). Science, 297, 1018–1023.

    Article  CAS  Google Scholar 

  • Bonni A, Brunet A, West AE, Datta SR, Takasu MA and Greenberg ME . (1999). Science, 286, 1358–1362.

    Article  CAS  Google Scholar 

  • Chien J and Shah GV . (2001). Int. J. Cancer, 91, 46–54.

  • Chikamatsu K, Reichert TE, Kashii Y, Saito T, Kawashiri S, Yamamoto E and Whiteside TL . (1999). Int. J. Cancer, 82, 532–537.

    Article  CAS  Google Scholar 

  • Cortesina GMT, Galeazzi E, Olivero M, De Stefani A, Bussi M, Valente G, Comoglio PM and Di Renzo MF . (2000). Int. J. Cancer, 89, 286–292.

    Article  CAS  Google Scholar 

  • Delehedde M, Lyon M, Gallagher JT, Rudland PS and Fernig DG . (2002). Biochem. J., 366, 235–244.

    Article  CAS  Google Scholar 

  • Dent P and Grant S . (2001). Clin. Cancer Res., 7, 775–783.

  • Dong G, Chen Z, Li ZY, Yeh NT, Bancroft CC and Van Waes C . (2001). Cancer Res., 61, 5911–5918.

  • Fleigel J, Sedwick J and Kornberg LJ . (2002). Otolaryngol. Head Neck Surg., 127, 271–278.

  • Galeazzi E, Olivero M, Gervasio FC, De Stefani A, Valente G, Comoglio PM, Di Renzo MF and Cortesina G . (1997). Eur. Arch. Otorhinolaryngol., 254, S138–S143.

  • Gescher A . (2000). Crit. Rev. Oncol. Hematol., 34, 127–135.

  • Gleich LL and Salamone FN . (2002). Cancer Control, 9, 369–378.

    Article  Google Scholar 

  • Hardisson D . (2003). Eur. Arch. Otorhinolaryngol., 8, 8.

  • Hughes RS and Frenkel EP . (1997). Am. J. Clin. Oncol., 20, 449–461.

  • Jeffers MRS and Woude GF . (1996). J. Mol. Med., 74, 505–513.

  • Katoh M . (2002). Int. J. Oncol., 21, 1269–1273.

  • Khurana D, Martin EA, Kasperbauer JL, O'Malley Jr BW, Salomao DR, Chen L and Strome SE . (2001). Head Neck, 23, 899–906.

    Article  CAS  Google Scholar 

  • Lai J, Chien J, Staub JK, Avula R, Greene EL, Matthews TA, Smith DI, Kaufmann SH, Roberts LR and Shridhar V . (2003). J. Biol. Chem., 278, 23107–23117.

    Article  CAS  Google Scholar 

  • Lai JP, Tong CL, Hong C, Xiao JY, Tao ZD, Zhang Z, Tong WM and Betz CS . (2002). Laryngoscope, 112, 402–408.

  • Liu D, Shriver Z, Qi Y, Venkataraman G and Sasisekharan R . (2002). Semin. Thromb. Hemost., 28, 67–78.

  • Lundin L, Larsson H, Kreuger J, Kanda S, Lindahl U, Salmivirta M and Claesson-Welsh L . (2000). J. Biol. Chem., 275, 24653–24660.

    Article  CAS  Google Scholar 

  • Lyon M, Deakin JA, Mizuno K, Nakamura T and Gallagher JT . (1994). J. Biol. Chem., 269, 11216–11223.

  • Matsumoto KMK, Nakamura T and Kramer RH . (1994). J. Biol. Chem., 269, 31807–31813.

  • Modjtahedi H and Dean C . (1995). Biochem. Biophys. Res. Commun., 207, 389–397.

  • Morimoto-Tomita M, Uchimura K, Werb Z, Hemmerich S and Rosen SD . (2002). J. Biol. Chem., 277, 49175–49185.

    Article  CAS  Google Scholar 

  • Riedel F, Gotte K, Bergler W, Rojas W and Hormann K . (2000). Head Neck, 22, 183–189.

  • Riedel F, Gotte K, Li M, Hormann K and Grandis JR . (2002). Int. J. Oncol., 21, 11–16.

  • Rubin JS, Day RM, Breckenridge D, Atabey N, Taylor WG, Stahl SJ, Wingfield PT, Kaufman JD, Schwall R and Bottaro DP . (2001). J. Biol. Chem., 276, 32977–32983.

    Article  CAS  Google Scholar 

  • Rong SS, Anver M, Resau JH and Woude GFV . (1994). Proc. Natl. Acad. Sci. USA, 91, 4731–4735.

  • Sasisekharan R, Shriver Z, Venkataraman G and Narayanasami U . (2002). Nat. Rev. Cancer, 2, 521–528.

  • Shridhar V, Sen A, Chien J, Staub J, Avula R, Kovats S, Lee J, Lillie J and Smith DI . (2002). Cancer Res., 62, 262–270.

  • Simon C, Nemechek AJ, Boyd D, O'Malley Jr BW, Goepfert H, Flaitz CM and Hicks MJ . (1998). Laryngoscope, 108, 1686–1691.

    Article  CAS  Google Scholar 

  • Strome SE, Kawakami K, Alejandro D, Voss S, Kasperbauer JL, Salomao D, Chen L, Maki RA and Puri RK . (2002). Clin. Cancer Res., 8, 281–286.

  • Vlachtsis K, Brieger J, Kim DW, Gieringer R, Hast J, Hengstler JG and Mann W . (2002). Oncol. Rep., 9, 1133–1138.

  • Wakulich C, Jackson-Boeters L, Daley TD and Wysocki GP . (2002). Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 93, 573–579.

  • Zeng Q, Chen S, You Z, Yang F, Carey TE, Saims D and Wang CY . (2002). J. Biol. Chem., 277, 25203–25208.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr Haidong Dong for help with FACS analysis. This work was supported by Mayo Foundation (to VS) and National Institutes of Health (CA82862 to LRR), an Industry Research Scholar Award from the Foundation of Digestive Health and Nutrition (to LRR).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Lewis R Roberts or Viji Shridhar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lai, JP., Chien, J., Strome, S. et al. HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma. Oncogene 23, 1439–1447 (2004). https://doi.org/10.1038/sj.onc.1207258

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207258

Keywords

This article is cited by

Search

Quick links